当前位置:首页 - 行情中心 - 嘉应制药(002198) - 财务分析 - 现金流量表

嘉应制药

(002198)

  

流通市值:34.31亿  总市值:34.31亿
流通股本:5.07亿   总股本:5.08亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金279,441,275.79187,810,725.5676,106,582.41423,016,598.59
  收到的税费返还93,641.6593,641.65--
  收到其他与经营活动有关的现金52,537,639.2452,073,554.7251,406,397.44,963,749.56
  经营活动现金流入小计332,072,556.68239,977,921.93127,512,979.81427,980,348.15
  购买商品、接受劳务支付的现金104,936,041.2350,570,089.6719,801,918.82107,984,743.28
  支付给职工以及为职工支付的现金40,831,690.9528,523,781.8114,229,137.3353,695,997.76
  支付的各项税费34,754,882.527,774,547.589,908,064.4345,548,445.03
  支付其他与经营活动有关的现金222,777,134.33158,494,858.395,407,614.06159,902,196.98
  经营活动现金流出小计403,299,749.01265,363,277.36139,346,734.64367,131,383.05
  经营活动产生的现金流量净额-71,227,192.33-25,385,355.43-11,833,754.8360,848,965.1
二、投资活动产生的现金流量:
  收回投资收到的现金5,226,224.151,008,599.15--
  取得投资收益收到的现金1,821,361.091,714,177.5235,833.334,995,155.92
  处置固定资产、无形资产和其他长期资产收回的现金净额---894,595.73
  处置子公司及其他营业单位收到的现金净额--1,435,878.37-
  收到的其他与投资活动有关的现金20,000,000-16,533,898.431,179,990,000
  投资活动现金流入小计27,047,585.242,722,776.6718,005,610.131,185,879,751.65
  购建固定资产、无形资产和其他长期资产支付的现金46,626,109.0718,913,056.367,352,833.2438,704,900.24
  投资支付的现金25,000,00029,505,606.6--
  支付其他与投资活动有关的现金20,000,000-20,000,000979,990,000
  投资活动现金流出小计91,626,109.0748,418,662.9627,352,833.241,018,694,900.24
  投资活动产生的现金流量净额-64,578,523.83-45,695,886.29-9,347,223.11167,184,851.41
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金--025,401,080.43
  支付其他与筹资活动有关的现金69,995,657.5761,301,621.5350,000,000-
  筹资活动现金流出小计69,995,657.5761,301,621.5350,000,00025,401,080.43
  筹资活动产生的现金流量净额-69,995,657.57-61,301,621.53-50,000,000-25,401,080.43
四、汇率变动对现金及现金等价物的影响-1,011,000-1,062,500--
五、现金及现金等价物净增加额-206,812,373.73-133,445,363.25-71,180,977.94202,632,736.08
  加:期初现金及现金等价物余额334,705,297334,705,297336,141,154.38132,072,560.92
  期末现金及现金等价物余额127,892,923.27201,259,933.75264,960,176.44334,705,297
补充资料:
  净利润-20,082,559.48-20,611,599.55
  资产减值准备-1,296,086.72-5,220,582.22
  固定资产和投资性房地产折旧-10,517,543.55-18,304,790.56
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-10,517,543.55-18,304,790.56
  无形资产摊销-658,564.5-1,317,128.99
  长期待摊费用摊销-610,231.36-85,941.79
  处置固定资产、无形资产和其他长期资产的损失-1,085.59--1,606,951.4
  固定资产报废损失---256,973.34
  公允价值变动损失-361,667.6--
  财务费用-289,236.34-3,955.04
  投资损失--415,663.13--675,010.43
  递延所得税--1,613,122.36--924,086.7
  其中:递延所得税资产减少--1,613,122.36--844,593.75
    递延所得税负债增加----79,492.95
  存货的减少-1,983,857.38-360,088.94
  经营性应收项目的减少--53,397,462.86-32,220,687.07
  经营性应付项目的增加--5,759,939.6--14,326,733.87
  现金的期末余额-201,259,933.75-334,705,297
  减:现金的期初余额-334,705,297-132,072,560.92
  现金及现金等价物的净增加额--133,445,363.25-202,632,736.08
公告日期2025-10-292025-08-262025-04-262025-04-26
审计意见(境内)标准无保留意见
TOP↑